Advertisement

Polycystic Ovarian Syndrome

Published:December 26, 2022DOI:https://doi.org/10.1016/j.mcna.2022.10.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Neven A.C.H.
        • Laven J.
        • Teede H.J.
        • et al.
        A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines.
        Semin Reprod Med. 2018; 36 (In eng): 5-12
        • Sadeghi H.M.
        • Adeli I.
        • Calina D.
        • et al.
        Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing.
        Int J Mol Sci. 2022; 23 (In eng)
        • Hoeger K.M.
        • Dokras A.
        • Piltonen T.
        Update on PCOS: consequences, challenges, and guiding treatment.
        J Clin Endocrinol Metab. 2021; 106 (In eng): e1071-e1083
        • Al Wattar B.H.
        • Fisher M.
        • Bevington L.
        • et al.
        Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study.
        J Clin Endocrinol Metab. 2021; 106 (In eng): 2436-2446
        • Teede H.J.
        • Misso M.L.
        • Costello M.F.
        • et al.
        Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
        Fertil Steril. 2018; 110 (In eng): 364-379
        • Barthelmess E.K.
        • Naz R.K.
        Polycystic ovary syndrome: current status and future perspective.
        Front Biosci (Elite Ed. 2014; 6 (In eng): 104-119
        • Yildiz B.O.
        • Bolour S.
        • Woods K.
        • et al.
        Visually scoring hirsutism.
        Hum Reprod Update. 2010; 16 (In eng): 51-64
        • The Rotterdam EAsPcwg
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
        Hum Reprod. 2004; 19: 41-47
        • Huddleston H.G.
        • Dokras A.
        Diagnosis and Treatment of Polycystic Ovary Syndrome.
        JAMA. 2022; 327 (In eng): 274-275
        • Bednarska S.
        • Siejka A.
        The pathogenesis and treatment of polycystic ovary syndrome: What's new?.
        Adv Clin Exp Med. 2017; 26 (In eng): 359-367
        • Gilbert E.W.
        • Tay C.T.
        • Hiam D.S.
        • et al.
        Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews.
        Clin Endocrinol (Oxf). 2018; 89 (In eng): 683-699
        • Cronin L.
        • Guyatt G.
        • Griffith L.
        • et al.
        Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).
        J Clin Endocrinol Metab. 1998; 83 (In eng): 1976-1987
        • Sam S.
        • Ehrmann D.A.
        Pathogenesis and Consequences of Disordered Sleep in PCOS.
        Clin Med Insights Reprod Health. 2019; 13 (1179558119871269. (In eng))https://doi.org/10.1177/1179558119871269
        • McCartney C.R.
        • Marshall J.C.
        CLINICAL PRACTICE. Polycystic Ovary Syndrome.
        N Engl J Med. 2016; 375 (In eng): 54-64
        • Lim S.S.
        • Hutchison S.K.
        • Van Ryswyk E.
        • et al.
        Lifestyle changes in women with polycystic ovary syndrome.
        Cochrane Database Syst Rev. 2019; 3 (In eng): Cd007506
        • Conway G.
        • Dewailly D.
        • Diamanti-Kandarakis E.
        • et al.
        The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
        Eur J Endocrinol. 2014; 171 (In eng): P1-P29
        • Wang R.
        • Li W.
        • Bordewijk E.M.
        • et al.
        First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
        Hum Reprod Update. 2019; 25 (In eng): 717-732
        • Jin P.
        • Xie Y.
        Treatment strategies for women with polycystic ovary syndrome.
        Gynecol Endocrinol. 2018; 34 (In eng): 272-277